Aurinia Q2 Beat with Revenue, Net Income Jump 21% and 60%
Aurinia Pharmaceuticals reported strong Q2 earnings with 21% revenue growth and a 60% increase in net income. The company also provided updated 2026 guidance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day